Top 10 Leading Companies in the Vietnam Pleurisy Market | Competitive Landscape 2026

Top 10 Leading Companies in the Vietnam Pleurisy Market

The Vietnam Pleurisy Market is created by a mix of established public firms and increasing private pharmaceutical brands. These companies influence the market with their high-capacity manufacturing, strategic international partnerships, and a focus on essential respiratory medications. Major players in the market include DHG Pharmaceutical Joint Stock Company, Traphaco Joint Stock Company, and Imexpharm Corporation.

Vietnam Pleurisy Market Overview

According to 6Wresearch, the market for Pleurisy in Vietnam is projected to experience steady expansion, driven by environmental factors, high prevalence of tuberculosis, and increased incidences of pneumonia and other respiratory tract infections. Pleurisy is known as an inflammation of the pleura, which often occurs as a secondary condition to primary infections.

The market expansion is further supported by the government's projects, which aims to increase the share of domestically produced pharmaceuticals. Growth is also fuelled by an elderly demographic and improved health insurance coverage, which has enhanced patient access to anti-inflammatory drugs and antibiotics necessary for treating pleuritic conditions.

Competitive Landscape

The competitive landscape of the Vietnam Pleurisy industry is determined by global standards, where local brands are upgrading to European standards. Leading brands have secured their lead by innovating generic antibiotics and analgesics for modern pulmonary treatments.

Below is a list of leading players operating in the Vietnam Pleurisy Market:

1. DHG Pharmaceutical Joint Stock Company (DHG Pharma)

DHG Pharma is a leading pharmaceutical manufacturer, offering a massive range of antibiotics and analgesics that are foundational in treating pleurisy.

2. Traphaco Joint Stock Company

Traphaco is highly regarded for its respiratory health products and its extensive distribution network across the country.

3. Domesco Medical Import Export Joint Stock Corporation

Domesco specializes in high-quality generic drugs, including corticosteroid treatments and antibiotics used for pleural inflammation.

4. Imexpharm Pharmaceutical Joint Stock Company

Imexpharm is known for its EU-GMP-compliant facilities, producing premium injectable antibiotics and oral medications for pulmonary care.

5. OPC Pharmaceutical Joint Stock Company

OPC is a leader in integrating traditional medicine with modern technology, providing unique herbal and chemical formulations for respiratory ailments.

6. Pymepharco Joint Stock Company (STADA Pymepharco)

Pymepharco focuses on healthcare, manufacturing advanced antibiotic lines used in hospital settings for severe pleurisy cases.

7. Cuu Long Pharmaceutical Joint Stock Company (Pharimexco)

Cuu Long Pharma is a major supplier of empty capsules and medical devices, as well as essential antibiotics and anti-infective agents for the domestic market.

8. Mekophar Chemical Pharmaceutical Joint Stock Company

Mekophar is one of the few companies with a biological research center, focusing on the production of a wide range of antibiotic tablets for respiratory infections.

9. Savipharm Joint Stock Company

Savipharm stands out for its high-tech R&D center and Japanese-GMP certification, producing sophisticated drug delivery systems for treating chronic lung-related conditions.

10. Bidiphar Pharmaceutical Joint Stock Company

Bidiphar is a pioneer in lyophilized powder for injection and anticancer medications, maintaining a strong presence in the supply of critical care drugs.

Top 10 Leading Companies in the Vietnam Pleurisy Market: FAQs